ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,629Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 198

$299K Total Retail Price of All Prescriptions

Rank: 109 out of 198

189 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 189 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 189 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,079 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
WARFARIN SODIUM 401 369 1 7
LEVOTHYROXINE SODIUM 330 321 2 1
FUROSEMIDE 329 312 3 5
POTASSIUM CHLORIDE 210 201 4 9
MIRTAZAPINE 207 202 5 44
LISINOPRIL 194 170 6 6
METOPROLOL TARTRATE 184 168 7 10
AMLODIPINE BESYLATE 173 173 8 4
DONEPEZIL HCL 166 147 9 28
SIMVASTATIN 157 149 10 2
OMEPRAZOLE 147 147 11 3
TRAMADOL HCL 143 141 12 15
SERTRALINE HCL 126 125 13 25
HYDROCODONE-ACETAMINOPHEN 117 99 S3 14 8
NAMENDA 115 90 15 33
GABAPENTIN 109 94 16 14
AZITHROMYCIN 100 97 17 56
METOPROLOL SUCCINATE 97 97 18 11
ATORVASTATIN CALCIUM 96 78 19 12
NYSTATIN 86 77 20 148
ALENDRONATE SODIUM 81 81 21 21
LIDOCAINE HCL 81 77 21 243
CEFTRIAXONE 80 76 23 244
GLIPIZIDE 79 63 24 62
METFORMIN HCL 79 70 24 13
POLYETHYLENE GLYCOL 3350 76 69 26 41
IPRATROPIUM-ALBUTEROL 76 76 26 180
ALLOPURINOL 69 69 28 23
ALBUTEROL SULFATE 69 67 28 113
PREDNISONE 64 62 30 29
KLOR-CON M10 63 63 31 125
METHYLPREDNISOLONE 61 59 32 167
CARVEDILOL 61 46 32 24
QUETIAPINE FUMARATE 60 59 34 76
OXYCODONE HCL 60 60 S2 34 112
DIVALPROEX SODIUM 58 58 36 122
HYDROCHLOROTHIAZIDE 54 45 37 16
CITALOPRAM HBR 51 51 38 20
ATENOLOL 51 51 38 17
OXYCODONE-ACETAMINOPHEN 50 45 S2 40 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.